Are you an HCP

In order to view our content, please indicate if you are an
Health Care Professional (HCP) to proceed:


No, I am not

How Skeletal Muscle Mass and Density Affects Treatment Toxicities and Outcomes in Cancer Patients

Prof. Michael Sawyer, MD Medical Oncologist/Clinical Pharmacologist - Cross Cancer Institute, Edmonton, Canada
Loading the player...